Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Tetra Bio-Pharma Inc. (C:TBP)

Business Focus: Alternative Medicine

Log in or join to add this stock to your watch list.
Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 2742 St. Joseph Blvd Unit 200
ORLEANS ON K1C 1G5
Tel: 1-514-3608040
Website: tetrabiopharma.com
IR: See website
Key People
Guy Chamberland
Chief Executive Officer, Chief Scientific Officer
Charles Campbell
Research Scientist
Sabino Di Paola
Chief Financial Officer
Richard Giguere
Executive Vice President - Commercial Operations
Steve Neron
Senior Vice President - Marketing and Medical Affairs
Robert Bechard
Vice President, Finance and Business Development
Denis Courchesne
Vice President of Sales
Edward Miller
Vice President of Investor Relations & Corporate Communications
Aurelia De Pauw
Vice President - Clinical Programs and Medical Affairs
Ryan Brown
Vice President - Business Development
   
Business Overview
Tetra Bio Pharma Inc is a Canada-based company engaged in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements. The Company is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. The Company objective is to bring smokable, natural medical marijuana to the market along with a number of other products targeting chronic pain, insomnia, post-traumatic stress disorder (PTSD), anxiety, among others. The Company operates through three divisions: PhytoPain Pharma Inc, Agro Tek Health and Grow Pros Cannabis Ventures Inc.
Financial Overview
For the six months ended 31 May 2019, Tetra Bio Pharma Inc revenues increased from C$0K to C$1.3M. Net loss increased 41% to C$6.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Payroll and benefits increase from C$430K to C$1.5M (expense), Research and development increase of 35% to C$3.3M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $59.54M as of May 31, 2019
Annual revenue (TTM): $1.43M as of May 31, 2019
EBITDA (TTM): -$12.74M as of May 31, 2019
Net annual income (TTM): -$9.60M as of May 31, 2019
Free cash flow (TTM): -$14.67M as of May 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 211,969,411 as of Jul 17, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization